A Phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(93)90312-l ◽

1993 ◽

Vol 10 (1-2) ◽

pp. 85-89

Author(s):

Nicholas A. Pavlidis ◽

George Klouvas ◽

Costas Nicolaides ◽

Apostolos Karantanas ◽

Marios Beer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study

Download Full-text

A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

Journal of Thoracic Oncology ◽

10.1097/01243894-200609000-00012 ◽

2006 ◽

Vol 1 (7) ◽

pp. 673-678 ◽

Author(s):

Gregory A. Masters ◽

Sigui Li ◽

Afshin Dowlati ◽

Stefan Madajewicz ◽

Corey Langer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study

Download Full-text

A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(15)30380-4 ◽

2006 ◽

Vol 1 (7) ◽

pp. 673-678

Author(s):

Gregory A. Masters ◽

Sigui Li ◽

Afshin Dowlati ◽

Stefan Madajewicz ◽

Corey Langer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study

Download Full-text

Phase II trial of high-dose cisplatin plus etoposide plus vinblastine in non-small-cell lung cancer. A hoosier oncology group study

Lung Cancer ◽

10.1016/0169-5002(92)90206-y ◽

1992 ◽

Vol 8 (2) ◽

pp. 139

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

High Dose ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study

Download Full-text

Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer: An Eastern Cooperative Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(95)96460-d ◽

1995 ◽

Vol 12 (1-2) ◽

pp. 155

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study

Download Full-text

Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(90)90231-a ◽

1990 ◽

Vol 6 (3-4) ◽

pp. 140

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study

Download Full-text

S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Multi-Institutional Phase II Trial (West Japan Thoracic Oncology Group 3706)

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182307e5a ◽

2011 ◽

Vol 6 (12) ◽

pp. 2069-2075 ◽

Author(s):

Yukito Ichinose ◽

Takashi Seto ◽

Tomonari Sasaki ◽

Takeharu Yamanaka ◽

Isamu Okamoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Oncology Group ◽

Small Cell Lung ◽

Concurrent Radiotherapy

Download Full-text

A randomized double-blind phase II trial of platinum (P) plus etoposide (E) with or without concurrent ZD6474 (Z) in patients (pts) with previously untreated extensive-stage (ES) small cell lung cancer (SCLC): Hoosier Oncology Group LUN06-113.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.7506 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 7506-7506 ◽

Author(s):

Rachel E. Sanborn ◽

Jyoti D. Patel ◽

Gregory A. Masters ◽

Nagesh Jayaram ◽

Anthony W. Stephens ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Small Cell Lung ◽

Double Blind ◽

Extensive Stage

Download Full-text

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

Journal of Thoracic Oncology ◽

10.1097/01243894-200611000-00013 ◽

2006 ◽

Vol 1 (9) ◽

pp. 996-1001 ◽

Author(s):

Primo N. Lara ◽

Kari Chansky ◽

Angela M. Davies ◽

Wilbur A. Franklin ◽

Paul H. Gumerlock ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Small Cell Lung ◽

Southwest Oncology Group ◽

Extensive Stage

Download Full-text

Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group 9914

Journal of Thoracic Oncology ◽

10.1097/01243894-200611000-00012 ◽

2006 ◽

Vol 1 (9) ◽

pp. 991-995 ◽

Author(s):

Paul J. Hesketh ◽

Jason McCoy ◽

Frank R. Dunphy ◽

James D. Bearden ◽

Geoffrey R. Weiss ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Small Cell Lung ◽

Southwest Oncology Group ◽

Extensive Stage

Download Full-text

Carboplatin (CBDCA) plus alpha interferon in metastatic non-small cell lung cancer: A Hoosier Oncology Group Phase II trial

Lung Cancer ◽

10.1016/0169-5002(94)90618-1 ◽

1994 ◽

Vol 11 (3-4) ◽

pp. 335

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Alpha Interferon ◽

Oncology Group ◽

Small Cell Lung

Download Full-text